Noopur Liffick

Noopur Liffick is Senior Vice President of Investor Relations and Corporate Communications at Chinook Therapeutics. With over 17 years of investor relations, communications and financial services experience in the healthcare industry and over $350 million in capital raised, Noopur has established a proven track record of managing relationships with the buy-side and sell-side. Noopur joined Chinook in October 2020 through the merger with Aduro Biotech where she served as Vice President and Head of Investor Relations and Corporate Communications. Prior to joining Aduro, Noopur was Vice President of Corporate Development at Rezolute where she oversaw investor relations, competitive intelligence, multiple financings and supported the in-licensing of two metabolic disease programs. Prior to joining AntriaBio, Noopur served as Vice President in the Healthcare practice at Gerson Lehrman Group (GLG), overseeing large segments of the company’s healthcare business in New York, Chicago and San Francisco. She currently serves on the board of Sairopa B.V. Noopur received her Master of Public Health from Columbia University in Health Policy and Management and Bachelor of Arts from University of California Berkeley in Molecular Cell Biology.